Ratios in Focus: Analyzing Citius Pharmaceuticals Inc (CTXR)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed at $0.53 up 9.02% from its previous closing price of $0.49. In other words, the price has increased by $9.02 from its previous closing price. On the day, 1.4 million shares were traded. CTXR stock price reached its highest trading level at $0.5468 during the session, while it also had its lowest trading level at $0.49.

Ratios:

For a deeper understanding of Citius Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.17 and its Current Ratio is at 5.17. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on November 30, 2021, initiated with a Buy rating and assigned the stock a target price of $4.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTXR now has a Market Capitalization of 95612152 and an Enterprise Value of 84027944.

Stock Price History:

The Beta on a monthly basis for CTXR is 1.68, which has changed by -0.56639344 over the last 52 weeks, in comparison to a change of 0.26253593 over the same period for the S&P500. Over the past 52 weeks, CTXR has reached a high of $1.28, while it has fallen to a 52-week low of $0.48. The 50-Day Moving Average of the stock is -19.39%, while the 200-Day Moving Average is calculated to be -27.48%.

Shares Statistics:

For the past three months, CTXR has traded an average of 1.88M shares per day and 3204520 over the past ten days. A total of 180.67M shares are outstanding, with a floating share count of 168.37M. Insiders hold about 6.81% of the company’s shares, while institutions hold 15.03% stake in the company. Shares short for CTXR as of 1718323200 were 15463236 with a Short Ratio of 8.25, compared to 1715731200 on 14481311. Therefore, it implies a Short% of Shares Outstanding of 15463236 and a Short% of Float of 9.1800004.

Earnings Estimates

The company has 1.0 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.06, while EPS last year was -$0.06. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.

Analysts are recommending an EPS of between -$0.23 and -$0.23 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is $0.06, with 1.0 analysts recommending between $0.06 and $0.06.

Revenue Estimates

Based on 2 analysts’ estimates, the company’s revenue will be $83.59M in the next fiscal year. The high estimate is $121.3M and the low estimate is $45.89M.

Most Popular